Press Release

  View printer-friendly version
<< Back
Dextera Surgical’s MicroCutter 5/80™ Honored as Finalist in 2017 Medical Design Excellence Awards

REDWOOD CITY, Calif.--(BUSINESS WIRE)--May 1, 2017-- Dextera Surgical Inc. (Nasdaq:DXTR) today announced that the MicroCutter 5/80™ has been selected as a finalist in the operating room tools and equipment category of the 19th Annual Medical Design Excellence Awards competition. Winners of the competition will be announced at the 2017 MDEA Ceremony on Tuesday, June 13, 2017.

The MDEA are the medtech industry’s premier design competition committed to recognizing significant achievements in medical product design and engineering that improve the quality of healthcare delivery and accessibility. The awards program celebrates the accomplishments of the medical device companies who are responsible for the cutting-edge products that are saving lives, improving patient healthcare, and transforming medtech—one innovation at a time.

“We are incredibly honored to be selected as a finalist in this competitive category and to be recognized among this year’s best medical innovations, providing validation for the innovative and unique design of our MicroCutter 5/80, the smallest articulating stapler in the world today,” said Julian Nikolchev, president and CEO of Dextera Surgical.

Liam Burns, vice president of worldwide sales and marketing added, “Our device enables less invasive procedures in multiple therapeutic areas. Currently, we are focusing our commercial efforts on video-assisted thoracic surgery, or VATS, where using the MicroCutter has been shown to reduce the length of hospital stays. Demand continues to grow in other surgical specialties, including pediatric surgery where the size of the MicroCutter 5/80 is a huge advantage. We look forward to bringing the benefits of this technology to more patients as we expand our launch activities for this breakthrough medical technology around the world.”

The 2017 MDEA Juror Panel selected exceptional finalists in nine medical technology product categories. Products were judged based on: patient benefits; design and engineering innovation; overall benefit to the healthcare system; function and user-related innovation; and business benefits. Unlike other design competitions that are merely styling contests, the MDEA jury comprises a balance of practicing surgeons, doctors, nurses, alongside industrial designers, engineers, manufacturers, and human factors experts.

MicroCutter Indication Information

The MicroCutter 5/80 Stapler and MicroCutter 30 Reloads are manufactured and cleared for use in the United States for transection and resection in multiple open or minimally invasive urologic, thoracic and pediatric surgical procedures, as well as application for transection, resection and/or creation of anastomoses in the small and large intestine, and the transection of the appendix. The MicroCutter 5/80 may be used with both MicroCutter 30 White Reloads in vascular/thin tissue and MicroCutter 30 Blue Reloads for standard tissue.

Forward-Looking Statements

The statements in this press release of a forward-looking nature are "forward-looking statements." There are a number of important factors that could cause Dextera Surgical’s results to differ materially from those indicated by these forward-looking statements, including the risks detailed from time to time in Dextera Surgical’s reports filed with the U.S. Securities and Exchange Commission, including its Quarterly Report on Form 10-Q for the quarter ended December 31, 2016, under the caption “Risk Factors.” Dextera Surgical expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein. You are encouraged to read Dextera Surgical’s reports filed with the U.S. Securities and Exchange Commission, available at

Source: Dextera Surgical Inc.

Dextera Surgical Inc.
Bob Newell, 650-331-7133
Vice President, Finance and Chief Financial Officer